Discovery of a Potent, Orally Active, Nonsteroidal Androgen Receptor Agonist: 4-Ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)-Reference-Cited by-同舟云学术

Discovery of a Potent, Orally Active, Nonsteroidal Androgen Receptor Agonist: 4-Ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)

Published:1999-01-01 Issue:2 Volume:42 Page:210-212
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Hamann Lawrence G.¹,Mani Neelakandha S.¹,Davis Robert L.¹,Wang Xiao-Ning¹,Marschke Keith B.¹,Jones Todd K.¹

Affiliation:

1. Departments of Medicinal Chemistry, Endocrine Research, and New Leads Discovery, Ligand Pharmaceuticals, Inc., 10275 Science Center Drive, San Diego, California 92121.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm9806648

Reference44 articles.

1. (a) Wilson, J. D. Chapter 58: Androgens. InGoodman and Gilman's ThePharmacological Basis of Therapeutics, 9 ed.; Hardman, J. G., Goodman, A. G., Limbird, L. E., Eds.; McGraw-Hill: New York, 1996; pp 1441−1457.

2. Biological Actions of Androgens

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The disordering effect of SARMs on a biomembrane model;Physical Chemistry Chemical Physics;2024

2. Lateral Deprotometallation‐Trapping Reactions on Methylated Pyridines, Quinolines and Quinoxalines Using Lithium Diethylamide;European Journal of Organic Chemistry;2023-08-07

3. Therapeutic Strategies to Target the Androgen Receptor;Journal of Medicinal Chemistry;2022-07-05

4. Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998–2021);European Journal of Medicinal Chemistry;2022-02

5. Highly enantioselective Ni-catalyzed asymmetric hydrogenation of β,β-disubstituted acrylic acids;Organic Chemistry Frontiers;2022